Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Revenue

Aprogen Medicines had revenue of 35.55B KRW in the quarter ending September 30, 2025, a decrease of -3.37%. This brings the company's revenue in the last twelve months to 126.09B, down -14.72% year-over-year. In the year 2024, Aprogen Medicines had annual revenue of 150.11B, down -0.31%.

• Revenue (ttm): 126.09B
• Revenue Growth: -14.72%
• P/S Ratio: 1.59
• Revenue / Employee: 492.55M
• Employees: 256
• Market Cap: 200.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	150.11B	-464.40M	-0.31%
Dec 31, 2023	150.58B	72.23B	92.19%
Dec 31, 2022	78.35B	52.05B	197.95%
Dec 31, 2021	26.30B	-100.85B	-79.32%
Dec 31, 2020	127.14B	48.89B	62.48%